Tag Archives: aerosol

New publication: Experimental methods for aerosol measurements in human airways

Experimental methods for flow and aerosol measurements in human airways and their replicas

Abstract

Recent developments in the prediction of local aerosol deposition in human lungs are driven by the fast development of computational simulations. Although such simulations provide results in unbeatable resolution, significant differences among distinct methods of calculation emphasize the need for highly precise experimental data in order to specify boundary conditions and for validation purposes.

This paper reviews and critically evaluates available methods for the measurement of single and disperse two-phase flows for the study of respiratory airflow and deposition of inhaled particles, performed both in vivo and in replicas of airways. Limitations and possibilities associated with the experimental methods are discussed and aspects of the computational calculations that can be validated are indicated.

Graphical abstract

The review classifies the methods into following categories:

  1. point-wise and planar methods for velocimetry in the airways,
  2. classic methods for the measurement of the regional distribution of inhaled particles,
  3. standard medical imaging methods applicable to the measurement of the regional aerosol distribution and
  4. emerging and nonconventional methods.

All methods are described, applications in human airways studies are illustrated, and recommendations for the most useful applications of each method are given.

Authors

Frantisek Lizal, Jan Jedelsky, Kaye Morgan, Katrin Bauer, Jordi Llop, Unai Cossio, Stavros Kassinos, Sylvia Verbanck, Jesús Ruiz-Cabello, Arnoldo Santos, Edmund Koch, Christian Schnabel

Source

Lizal, F., Jedelsky, J., Morgan, K., Bauer, K., Llop, J., Cossio, U., … & Koch, E. (2017). Experimental methods for flow and aerosol measurements in human airways and their replicas. European Journal of Pharmaceutical Sciences.

__________________________________________________________________

Read more PneumoNP news

cropped-Logo_PneumoNP_Simple_PRINT-01.png

Join the Molecular Imaging Workshop 2017

The second edition of the Molecular Imaging Workshop 2017 (MIW2017) will be held from 20th to 23rd November 2017 in San Sebastian, ...
Read More
ETP Nanomedicine is the European Forum aiming at developping, supporting and promoting the field of nanotechnologies applied to medicine.
ETP Nanomedicine translates business, clinical interface, toxicology and characterisation, education and training, ethics and social impact to pursue its goal. Indeed, the organisation intent is to enable diagnostics and imaging, therapy and targeted delivery, and regenerative medicine.

Meet us at the ETPN2017 event

PneumoNP partners will attend the ETPNanomedicine event in Malaga, Spain from 17th to 19th October 2017. The European Technology Platform on ...
Read More
FIGON Conference

Meet us at the FIGON Dutch Medicine Days

PneumoNP partners will attend FIGON Dutch Medicine Days in Ede, the Netherlands on 2nd and 3rd of October 2017. ...
Read More

A step forward towards therapeutic aerosols

A delivery device for a breathable drug has been prototyped to test a new drug formulation. It aims to fight respiratory tract infections.

To cure infections located in lungs, you can deliver antibiotic through the blood vessels or directly via the airways. Despite the many advantages of pulmonary delivery, few nebulization systems are designed.

The PneumoNP project develops an antibiotic formulation acting against drug resistant pneumonia. As it aimed for inhaled therapy, an aerosol system was chosen to deliver it. The Spanish company Ingeniatrics Technologías S.L. is in charge of prototyping the nebulizer device.

The Flow Blurring® nebulizer (©Ingeniatrics Technologías S.L.)

Picture 1: The Flow Blurring® nebulizer (©Ingeniatrics Technologías S.L.)

Setting up a nebulizer requires more than a random combination of compressed air and liquid. Indeed, the output needs to fulfill many conditions to be efficient.  Amongst others, the mist has to be breathable. So, droplets should be smaller than 3 μm to reach each corner of the lung. Achieving this result was especially challenging as the drug formulation contained large molecules.

Ingeniatrics used its technology called Flow Blurring® to produce the aerosol prototype. The Flow Blurring® relies on an atomisation technique that creates an ultra-fine mist from liquid; besides, it requires less energy compared to collision nebulizers. The microfluidic system produces turbulent mixing between a compressed air and the liquid drug. It yields droplets that are smaller than the output pipe. The system is versatile including, not only the proper fluid delivery accessories, but also the possibility to use mist chambers in combination with the Flow Blurring® technology.

illustration-scientifique-aerosol-v01-01

Picture 2: The Flow Blurring® technology adapted to drug delivery

As of today, the prototype is already in function. In the Dutch Erasmus Medical Center and in the Spanish CIC Biomagune laboratories, rats have been accustomed to the prototype setup. Now, researchers can look at the healing time of the rats when they inhale the drug. Initially designed for these in-vivo tests on rodents, the aerosol prototype has also been adapted to in-vitro investigations. In particular, researchers of the German Fraunhofer ITEM expose human epithelial lung cells to the therapeutic mist. They measure cytotoxicity and efficiency indices with this setup.

The aerosol delivery prototype will benefit from these users’ feedbacks for further refinement of the system. If the aerosol system is promising enough, it may become an industrial medical device for human or animal use.

__________________________________________________________________

Learn more on Ingeniatrics’ activities

__________________________________________________________________

Read more PneumoNP news

cropped-Logo_PneumoNP_Simple_PRINT-01.png

Join the Molecular Imaging Workshop 2017

The second edition of the Molecular Imaging Workshop 2017 (MIW2017) will be held from 20th to 23rd November 2017 in San Sebastian, ...
Read More
ETP Nanomedicine is the European Forum aiming at developping, supporting and promoting the field of nanotechnologies applied to medicine.
ETP Nanomedicine translates business, clinical interface, toxicology and characterisation, education and training, ethics and social impact to pursue its goal. Indeed, the organisation intent is to enable diagnostics and imaging, therapy and targeted delivery, and regenerative medicine.

Meet us at the ETPN2017 event

PneumoNP partners will attend the ETPNanomedicine event in Malaga, Spain from 17th to 19th October 2017. The European Technology Platform on ...
Read More
FIGON Conference

Meet us at the FIGON Dutch Medicine Days

PneumoNP partners will attend FIGON Dutch Medicine Days in Ede, the Netherlands on 2nd and 3rd of October 2017. ...
Read More